Fshd Global Research Foundation
FoundationSydney South · Seed
Find your way into Fshd Global Research Foundation
Sign up to see every warm intro you have to Fshd Global Research Foundation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fshd Global Research Foundation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The Foundation pursues treatments and an ultimate cure for FSHD, a progressive genetic muscle-wasting disease, while improving quality of life for those affected. Its work rests on three pillars: finding a cure through medical grants, biotech investment and clinical trial pathways; muscle regeneration via investment in muscle wellness and technologies; and patient and medical advocacy to advance diagnostic and medical infrastructure and ensure access to approved therapies. It supports well-managed biotechnology companies developing novel FSHD treatments or technologies to improve musculoskeletal health, strength and wellbeing. Funding comes through active fundraising, signature events, corporate partnerships and donations.
Source: firm website, verified Oct 2, 2026.
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Digital Health ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathAltay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ali Ozes(Founder)inOsman Ozes(Founder)inJAMES BREITMEYER(Executive Officer, Director)ERIC BJERKHOLT(Director)MIKE GREY(Director)ESTER SKLARSKY(Director)
Co-investorsCreative Destruction Lab (CDL)Jude GomilaTachyon VenturesY Combinator
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Facio BioTherapies
Frequently asked questions
- What stage does Fshd Global Research Foundation invest at?
- Fshd Global Research Foundation invests at the Seed stage.
- What sectors does Fshd Global Research Foundation focus on?
- Fshd Global Research Foundation focuses on Biotech, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is Fshd Global Research Foundation located?
- Fshd Global Research Foundation is headquartered in Sydney South, AU.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
ORI Capital is a venture capital firm, founded in 2015, that invests globally in innovative early-stage biotech companies across diagnostics, drug delivery, and therapeutics.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.







